Abstract

Specialty pharmacy drugs (SP-D) are high-cost and for the treatment of complex conditions, e.g., cancer (O). High medication adherence and quality of life (QoL) contribute to desired treatment outcomes. SP Medication Therapy Management (SPMTM) contributes to optimal QoL and adherence; therefore, the objective is to compare adherence to oral O-SP-D with QoL metrics reported by O patients who participated in SPMTM before and after Start of Care (SOC).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.